| Literature DB >> 33868337 |
Jeehee Roh1, Jinyoung Moon1, Ye Eun Lee1, Chan Ho Park2, Seong-Ki Kim1.
Abstract
Brachypodium distachyon is a monocotyledonous model plant that contains castasterone (CS) but no brassinolide (BL) as the end product of brassinosteroids (BR) biosynthesis, indicating dysfunction of BL synthase, which catalyzes the conversion of CS to BL. To increase BR activity, Arabidopsis cytochrome P450 85A2 (AtCYP85A2) encoding BR 6-oxidase/BL synthase was introduced into B. distachyon with the seed-specific promoters pBSU1, pAt5g10120, and pAt5g54000. RT-PCR analysis and GUS activity revealed that AtCYP85A2 was only expressed in the seeds of the transgenic plants pBSU1-AtCYP85A2::Bd21-3, pAt5g10120-AtCYP85A2::Bd21-3, and pAt5g54000-AtCYP85A2::Bd21-3. The crude enzyme prepared from the seeds of these three transgenic plants catalyzed the conversion of 6-deoxoCS to CS. The transgenic plants showed greater specific enzyme activity than the wild-type plant for the conversion of 6-deoxoCS to CS, indicating enhanced BR 6-oxidase activity in the transgenic plants. The enzyme solution also catalyzed the conversion of CS into BL. Additionally, BL was identified from the seeds of transgenic plants, verifying that seed-specific AtCYP85A2 encodes a functional BL synthase to increase BR activity in the seeds of transgenic Brachypodium. In comparison with wild-type Brachypodium, the transgenic plants showed better growth and development during the vegetative growing stage. The flowers of the transgenic plants were remarkably larger, resulting in increments in the number, size, and height of seeds. The total starch, protein, and lipid contents in transgenic plants were higher than those in wild-type plants, indicating that seed-specific expression of AtCYP85A2 improves both grain yield and quality in B. distachyon.Entities:
Keywords: Arabidopsis CYP85A2; BR 6-oxidase/BL synthase; Brachypodium distachyon; seed yield and quality; seed-specific expression
Year: 2021 PMID: 33868337 PMCID: PMC8047465 DOI: 10.3389/fpls.2021.639508
Source DB: PubMed Journal: Front Plant Sci ISSN: 1664-462X Impact factor: 5.753
Figure 1Chemical structure for brassinosteroids mentioned in this study. 6-DeoxoCS, 6-deoxocastasterone; CS, castasterone; BL, brassinolide.
Figure 2Preparation of seed-specific AtCYP85A2-expressing transgenic Brachypodium. (A) Region of embryonic cells (red circle) dissecting from immature seed of Bd21-3, the wild type Brachypodium. (B) Calli induced from embryonic cells in callus induction media (CIM). (C) Hygromycin resistant yellowish-brown calli after agrobacterium-mediated transformation. Red circle indicates the selected calli. (D) Regenerated shoot from AtCYP85A2-expressing callus in regeneration medium (ReM) for 7 days. (E) Regenerated shoot and root from AtCYP85A2-expressing callus in ReM for 21 days. (F) AtCYP85A2-expressing transgenic Brachypodium plants.
Figure 3Genetic map of seed-specific AtCYP85A2-expressing constructs and expression level of AtCYP85A2 in transgenic Brachypodium mutants. (A) Genetic map of AtCYP85A2 expressing constructs driven by seed specific promoters, pBSU1, pAt5g10120, and pAt5g54000. CaMV polyA signal, the cauliflower mosaic virus polyadenylation signal; HygR, hygromycin resistance gene; CaMV 35S promoter, the cauliflower mosaic virus 35S promoter; GUS, β-glucuronidase gene; NOS terminator, nopaline synthase terminator; LB, left border; RB, right border. (B) Semi-quantitative RT-PCR analysis for expression of AtCYP85A2 in shoot, root, and seed of wild type and transgenic plants. #1 and #2 represent two different lines for three transgenic plants. AtCYP85A2 was only detected in seed of transgenic plants. BdGAPDH is a reference gene. (C) GUS-staining in leaf, root and seed of transgenic Brachypodium mutants. GUS activity was concentrated in seed of transgenic plants.
Quantification of endogenous BRs (6-deoxoCS, CS, and BL) in seeds of Brachypodium.
| 6-DeoxoCS | 40–42 | 0.735 | 498(M+, 48), 483(14), 343(7), 273(100), 155(83) | 5.29 (0.87) |
| CS | 22/23 | 1.000 | 512(M+, 12), 357(24), 327(21), 287(42), 155(100) | 1.55 (0.26) |
| BL | N.D. | N.D. | N.D. | N.D. |
| 6-DeoxoCS | 40–42 | 0.735 | 498(M+, 52), 483(18), 343(11), 273(100), 155(91) | 2.46 (0.48) |
| CS | 22/23 | 1.000 | 512(M+, 8), 357(17), 327(14), 287(35), 155(100) | 1.83 (0.33) |
| BL | 13/14 | 1.300 | 528(M+, 6), 374(33), 332(49), 177(71), 155(100) | 2.55 (0.57) |
| 6-DeoxoCS | 40–42 | 0.735 | 498(M+, 54), 483(20), 343(16), 273(100), 155(94) | 3.73 (0.73) |
| CS | 22/23 | 1.000 | 512(M+, 9), 357(21), 327(14), 287(37), 155(100) | 1.79 (0.31) |
| BL | 13/14 | 1.300 | 528(M+, 3), 374(29), 332(42), 177(69), 155(100) | 2.24 (0.42) |
| 6-DeoxoCS | 40–42 | 0.735 | 498(M+, 50), 483(17), 343(10), 273(100), 155(89) | 1.48 (0.25) |
| CS | 22/23 | 1.000 | 512(M+, 10), 357(20), 327(16), 287(36), 155(100) | 1.97 (0.41) |
| BL | 13/14 | 1.300 | 528(M+, 5), 374(32), 332(47), 177(72), 155(100) | 4.19 (0.98) |
| Authentic 6-DeoxoCS | 40–42 | 0.735 | 498(M+, 50), 483(17), 343(10), 273(100), 155(89) | - |
| Authentic CS | 22/23 | 1.000 | 512(M+, 11), 357(21), 327(19), 287(36), 155(100) | - |
| Authentic BL | 13/14 | 1.300 | 528(M+, 5), 374(31), 332(42), 177(74), 155(100) | - |
The sample was analyzed as a bismethanboronate in GC-MS/SIM analysis.
Rt : Retention time (min).
RRt : Relative retention time to CS (15.01 min).
Amount is denoted as ng g.
Not detected.
Figure 4Distribution of BR activity after a reversed phase HPLC. HPLC was carried out using a C18 column (SenshuPak, 10 × 150 mm) at flow 2.5 mL min−1 using MeCN-water gradients: 0–20 min, 45% MeCN; 20–40 min, 45–100% MeCN gradient; 40–70 min, 100% MeCN. Fractions were collected every minute. The arrow indicates the elution points of authentic BRs. Activities shown were measured by rice lamina inclination assay. The average of 20 rice segments was calculated in every fraction. The dotted line represents the average biological activity after application of no BRs (Control) and BL 0.001 ppm. (A) The biological activity after HPLC when 6-deoxoCS was used as a substrate. (B) The biological activity after HPLC when CS was used as substrate.
Conversion of 6-deoxoCS and CS by the crude enzyme solution prepared from Brachypodium.
| Shoot/Root | 6-DeoxoCS | CS | 1.70 (0.32) |
| CS | N.D. | - | |
| Seed | 6-DeoxoCS | CS | 1.58 (0.39) |
| CS | N.D. | - | |
| Shoot/Root | 6-DeoxoCS | CS | 1.80 (0.48) |
| CS | N.D. | - | |
| Seed | 6-DeoxoCS | CS | 1.90 (0.57) |
| CS | BL | 1.14 (0.26) | |
| Shoot/Root | 6-DeoxoCS | CS | 1.75 (0.41) |
| CS | N.D. | - | |
| Seed | 6-DeoxoCS | CS | 1.83 (0.42) |
| CS | BL | 0.60 (0.11) | |
| Shoot/Root | 6-DeoxoCS | CS | 1.82 (0.43) |
| CS | N.D. | - | |
| Seed | 6-DeoxoCS | CS | 2.03 (0.62) |
| CS | BL | 1.59 (0.27) | |
The sample was analyzed as a bismethanboronate in GC-MS/SIM analysis.
Activity is denoted as ng mg.
Not Detected.
Figure 5Expression of BR related and seed size determination genes in transgenic Brachypodium mutants. (A) Semi-qPCR of BR metabolic genes. BdDET2(Bradi2g55110), BdDWF4(Bradi1g69040), and BdCYP85A1(Bradi1g15030) for BR biosynthesis. BdBAS1(Bradi2g04660) and BdSOB7(Bradi2g44140) for BR catabolism. (B) Semi-qPCR of BR signaling and seed size-determining genes. BdBRI1(Bradi2g48280) and BdBZR1(Bradi1g23550) for BR signaling. BdPHO1-2 (BdSHB1, Bradi3g54920) and BdIKU2(Bradi4g11740) for seed size determination. #1 and #2 represent two different lines for three transgenic plants. Semi-qRT-PCR was performed with total RNA. BdGAPDH was used to normalize the expression level. Two biological repeats along with three technical repeats were performed for quantification of gene expression level. The asterisks indicate the statistical significance of the Student's t-test: * (P < 0.05), ** (P < 0.01), and *** (P < 0.001).
Figure 6Phenotypic alterations of transgenic Brachypodium in vegetative growth. (A) Seedling growth of wild type and transgenic Brachypodium. Seedlings were grown in MS medium for 3 weeks. (B) Length of shoot and root in seedling of wild type and transgenic Brachypodium. (C) Phenotype of adult plants in wild type and transgenic Brachypodium. Plants were grown in soil for 6 weeks. (D) Length of stem, root, and number of branched leaves in wild type and transgenic Brachypodium. #1 and #2 represent two different lines for three transgenic plants. The scale bar in (A) and (C) indicates 1 cm. Each dot in (B) and (D) indicates individual data. Red and black line represents the mean of the individual measurements and the standard deviation (S.D.), respectively. The asterisks indicate the statistical significance of the Student's t-test: * (P < 0.05), ** (P < 0.01), and *** (P < 0.001).
Figure 7Alterations of phenotype and contents of primary metabolites in seeds of transgenic Brachypodium. (A) Size of flower in wild type and transgenic Brachypodium. The scale bar in (A) indicates 1 cm. (B) Number of seeds in a flower in wild type and transgenic Brachypodium. (C) Shape of seeds in wild type and transgenic Brachypodium. The scale bar in (C) indicates 50 mm. (D) Size and mass of seeds in wild type and transgenic Brachypodium. (E) Total starch, proteins, and lipids content of seeds in wild type and transgenic Brachypodium. #1 and #2 represent two different lines for three transgenic plants. Each dot in (B,D,E) indicates individual data. Red and black line represents the mean of the individual measurements and the standard deviation (S.D.), respectively. Asterisks indicate the statistical significance of the Student's t-test: ** (P < 0.01) and *** (P < 0.001).